It is currently Sat Nov 01, 2014 3:23 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Copaxone at ECTRIMS

Glatiramer Acetate Shows Positive Impact on Average Relapse Rate and Disease Progression in Multiple Sclerosis For Up to 5 Years: Presented at ECTRIMS
By Bruce Sylvester

MADRID, SPAIN -- October 1, 2006 -- Treatment of relapsing-remitting multiple sclerosis (MS) with glatiramer-acetate (glatiramer, Copaxone) is safe and effective, and it has a positive impact on average relapse rate and disease progression scores.

The findings were presented here on September 28th at the 22nd Congress of the ...
Read more : Copaxone at ECTRIMS | Views : 1873 | Replies : 0 | Forum : Copaxone


Forgot the name of a website

Can anyone tell me the name of that website for pharmaceutical "professionals"? It's the one with all of the potty mouth newbie drug reps. I'm trying to find out who the Biogen rep for my area is.
Read more : Forgot the name of a website | Views : 1443 | Replies : 2 | Forum : General Discussion


Biogen gets in on CDP323

Looks like Biogen is really trying to corner the market on new MS treatments.



UCB and Biogen Idec to Collaborate on Oral Multiple Sclerosis Therapy

MARKET WIRE -- October 02, 2006 -- UCB and Biogen Idec today announced a global collaboration to jointly develop and commercialize CDP323 for the treatment of relapsing-remitting multiple sclerosis (MS) and other potential indications. CDP323 is an orally active small molecule alpha4-integrin inhibitor expected to enter Phase II clinical trials ...
Read more : Biogen gets in on CDP323 | Views : 2675 | Replies : 1 | Forum : Drug Pipeline


Disability, axonal degeneration

I have been reading a little and understanding a little on this axonal degeneration and disability connection. Gary has lots of disability and little brain lesions, so it "fits" his MS. A few years ago they did a spinal MRI and a DR noted in a known area of attacks spinal atrophy. Which basically is shrinkage? I read in Lyon's article on another post about all of this except they were talking about the brain ...
Read more : Disability, axonal degeneration | Views : 3290 | Replies : 20 | Forum : General Discussion


Cyclophosphamide

This is a story of a couple of months ago, but is doing the rounds again. It's something cheery for a Monday.

Ian


MS treatment 'a miracle'

Rocky Point woman undergoes high-dose regimen at Stony Brook.
Linda Jacobellis had multiple sclerosis, a disease for which there is no cure, for 16 years. Now, she announces, "I no longer have MS." She ascribes her cure, in part, to "a miracle from my mother in heaven." ...
Read more : Cyclophosphamide | Views : 1940 | Replies : 6 | Forum : General Discussion


Genes story

This looks an interesing genes story


http://news.bbc.co.uk/1/hi/health/5379250.stm
Read more : Genes story | Views : 1039 | Replies : 0 | Forum : General Discussion


Spiritual healing, medically verifiable. 170 lectures in U.S

Hi, my name is Neal and I want to share something very special with you. Please read below and before being critical, convince yourselves. Everyone has a duty to do this. What I am sharing you has helped me alot and has been a great gift in my life and thousands of others. But like I said, convince yourself. You can email me at nadidas99@msn.com if you have questions. Also, ...


WRONG PLACE?

hello all, new to this forum and copaxone and had a question.

was wondering if anyone else has had the same experience or could tell me what happened? :cry:

i have only been doing the shots for 2 weeks now and use the autoinject, and last week when i did my legs all was fine, but this week, the right leg when i gave ...
Read more : WRONG PLACE? | Views : 2287 | Replies : 4 | Forum : Copaxone


Betaferon and the BENEFIT study

Betaferon Demonstrates Robust Reduction in Risk of Developing Multiple Sclerosis Across All Subgroups of Benefit study



BERLIN, September 29, 2006-Schering AG (FSE: SCH, NYSE: SHR), Germany, announced today results from the subgroup analysis of the BENEFIT* study which showed that Betaferon® (interferon beta-1b) 250mcg treatment reduced the risk of developing clinically definite MS (CDMS) consistently across all subgroups regardless of age, gender, steroid treatment or symptoms at onset of disease.1 These data were part of ...
Read more : Betaferon and the BENEFIT study | Views : 832 | Replies : 0 | Forum : General Discussion


swollen lymph nodes

I have been on Rebif for about a month and a half now. I am getting swelling in the lymph nodes and around the front of the ear on the edge of the face. Slightly sore. Is this a common side effect with Rebif?
Robin
Read more : swollen lymph nodes | Views : 5125 | Replies : 5 | Forum : Rebif


 

Login  •  Register


Statistics

Total posts 221024 • Total topics 22918 • Total members 14474


Contact us | Terms of Service